跳至主要内容
临床试验/NCT01274702
NCT01274702已完成2 期

Visual Reconstitution Therapy After Optic Neuritis

Friedemann Paul2 个研究点 分布在 1 个国家目标入组 25 人开始时间: 2010年5月最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
25
试验地点
2
主要终点
Visual field

研究概览

简要总结

Incomplete remission after an optic neuritis attack is not uncommon. Visual reconstitution therapy is a software-based approach that has been shown to substantially improve residual visual field deficits in patients with pre- and postchiasmatic lesions.

The primary hypothesis of this randomized, controlled clinical trial is, that visual reconstitution therapy is superior to active comparator treatment in improving the visual field after optic neuritis.

详细描述

Patients with an acute optic neuritis (between 60 and 180 days before screening) or with residual visual deficits after a past optic neuritis are randomized in two treatment groups. Group A is instructed to perform software-based visual reconstitution therapy on a home PC daily and regularly for 30 minutes over a period of six month. Group B will perform a similarly, also software-based training program, developed to improve saccadic eye movements rather than visual fields. Patients are blinded to the respective treatment.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Participant)

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Definite Optic Neuritis within 60-180 Days or < 12 months before Screening
  • Visus > 0.05
  • Visus < 0.7 or confirmed visual field deficit
  • Ability to give Informed Consent

排除标准

  • Systemic Treatment with Glucocorticosteroids within 30 days prior to Screening
  • Additional significant ophthalmological disease
  • Pregnancy
  • History of Epilepsy
  • Significant arterial Hypertension

结局指标

主要结局

Visual field

时间窗: 6 months

visual field perimetry and kampimetry at baseline and after 3 and 6 months

次要结局

  • Quality of Life(6 months)
  • structural retinal changes(6 months)

研究者

发起方
Friedemann Paul
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Friedemann Paul

Prof. Dr.

Charite University, Berlin, Germany

研究点 (2)

Loading locations...

相似试验